JPRN-UMIN000045957已完成未知
To evaluate the efficacy of once-weekly DPP-4 inhibitor:Omarigliptin for liver function of type 2 diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis - To evaluate the efficacy of Omarigliptin for liver function of type 2 diabetic patients with NAFLD/NASH
Department of Diabetes and Metabolism,Tohto Clinic0 个研究点目标入组 26 人开始时间: 2021年11月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pregnant or being pregnant within the study 2)Contraindication with Dipeptidyl peptidase 4 inhibitor
研究者
相似试验
进行中（未招募）
不适用
valuation of the effect of a new drug for diabetes on atherosclerosis in patients with primary failure metformiType 2 diabetesMedDRA version: 14.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-000152-34-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA64
招募中
不适用
The clinical study to explore the effects of DPP-4 inhibitors on responses of lipidType 2 DiabetesJPRN-UMIN000020968Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine60
已完成
不适用
Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000011862aka Kinen Clinic10
进行中（未招募）
不适用
A Study to Evaluate Two Different Medicines on Daily Changes in Lung function in COPDEUCTR2012-000384-24-GBGlaxoSmithKline Research & Development Limited56
已完成
不适用
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30